Published December 5, 2023
| Version v1
Conference paper
Open
ARTERIAL GIPERTENZIYALI BEMORLARDA YASHIRIN SURUNKALI YURAK YETISHMOVCHILIGINI ANIQLASH
Creators
- 1. Toshkent tibbiyot akademiyasi, Toshkent, O`zbekiston
Description
Uzoq muddat arterial gipertenziya bilan og'rigan bemorlarda yurakdagi tizimli va funktsional o'zgarishlar surunkali yurak yetishmovchiligi rivojlanishiga olib kelishi mumkin. Qon bosimini boshqarish nafaqat surunkali yurak yetishmovchiligni yuzaga kelishini va nishon organ shikastlanishining oldini oladi, balki kasallikning keyingi rivojlanishiga ta'sir ko'rsatish orqali bemor hayot sifatini yaxshilaydi.
Files
19-20 Azamatov B.Q.pdf
Files
(583.6 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:4f1e95bc7c306b09ab2c6ea02672f5b9
|
583.6 kB | Preview Download |
Additional details
References
- 1. S. Bangalore, D. Wild, S. Parkar, M. Kukin, F.H. Messerli Beta-blockers for primary prevention of heart failure in patients with hypertension insights from a meta-analysis J Am Coll Cardiol, 52 (2008), pp. 1062-1072
- 2. N. Chen, M. Zhou, M. Yang, et al. Calcium channel blockers versus other classes of drugs for hypertension Cochrane Database Syst Rev, 8 (2010), p. CD003654
- 3. C.G. Crandall, R.A. Etzel, J.M. Johnson, Evidence of functional β-adrenoceptors in the cutaneous vasculature" Am J Physiol, 273 (1997), pp. H1038-1043
- 4. Mini-Focus Issue: Cardiovascular Comorbidities State-of-the-Art Review ,,The Transition From Hypertension to Heart Failure: Contemporary Update'' Franz H. Messerli MD a b c, Stefano F. Rimoldi MD a, Sripal Bangalore MD d
- 5. Jumanazarov, S., Jabbarov, O., Umarova, Z., Tursunova, L., & Mirzayeva, G. (2022). Factors affecting platelet hemostasis and resistance to curantil in patients with chronic kidney disease.
- 6. Jabbarov, O. O., Daminov, B. T., & Tursunova, L. D. (2019). Роль метаболических факторов в прогрессировании диабетической нефропатии. Вестник Ташкентской медицинской академии, (4), 25-29.
- 7. Tursunova, L. D., & Jabbarov, O. O. (2021). APPLICATION OF SAKABUTRIL/VALSARTAN IN PATIENTS WITH CHRONIC KIDNEY DISEASE WITH TYPE 2 DIABETES MELLITUS. Art of Medicine. International Medical Scientific Journal, 1(1).